ILItzel Yanira López-Peña

Itzel Yanira López-Peña

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Itzel Yanira López-Peña has a total of 26 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Gelatin–Curcumin Nanoparticles Produced by Uniaxial Electrospraying: Rheological Behavior of Precursor Gelatin Solutions and Physicochemical Characterization of Nanoparticles

    by Ana Victoria Tapia-Gastélum, Carlos Gregorio Barreras-Urbina, José Agustín Tapia-Hernández, Francisco Rodríguez-Félix, Tomás Jesús Madera-Santana, Lorena Armenta-Villegas, Abril Zoraida Graciano-Verdugo, Itzel Yanira López-Peña, Betzabe Ebenhezer López-Corona, María Jesús Moreno-Vásquez, et al.

    Electrospraying has emerged as a promising technique for producing biopolymeric structures containing bioactive compounds. In this study, gelatin and gelatin–curcumin nanoparticles were produced by uniaxial electrospraying, and the effects of gelatin and curcumin extract concentrations on their rheological, morphological, and physicochemical characteristics were evaluated. Gelatin solutions (5–15% w/v) were first characterized by rheological analysis, which exhibited Newtonian flow behavior over the evaluated concentration range, favorable for the electrospraying process. Electrospraying was performed at fixed conditions of 15 kV voltage, 0.1 mL h−1 flow rate, and 10 cm tip-to-collector distance. Increasing gelatin concentrations influenced the resulting morphology, with structures ranging from pearled fibers to spherical particles and, at higher concentrations, fibers with few pearls. Gelatin structures exhibited mean hydrodynamic diameters of 420.63–762.66 nm, determined by dynamic light scattering (DLS), with PDI values of 0.49–0.89. At a fixed gelatin concentration of 8% (w/v), varying curcumin extract concentration from 1 to 5% (w/v) resulted in a non-linear change in particle size, with mean diameters ranging from 196.30 to 622.16 nm and PDI values of 0.60–0.79. The selected formulation containing 8% (w/v) gelatin and 5% (w/v) curcumin extract exhibited the highest absolute zeta potential (−28.56 ± 1.25 mV), suggesting a lower tendency toward particle aggregation. Fourier transform infrared spectroscopy (FTIR) supported molecular interactions between gelatin and curcumin. Overall, the results demonstrate that formulation composition influences the morphology, particle size distribution, and surface charge of gelatin–curcumin structures produced by uniaxial electrospraying. Further studies are required to evaluate encapsulation efficiency, curcumin storage stability, release behavior, and biological performance.

  • Open Access

    Formulation and Physicochemical Characterization of Gelatin–Curcuma longa L. Extract Nanoparticles Prepared by Coaxial Electrospraying

    by Sebastián Guzmán-León, Carlos Gregorio Barreras-Urbina, Tomás Jesús Madera-Santana, Lorena Armenta-Villegas, Maritza Lizeth Álvarez-Ainza, José Agustín Tapia-Hernández, Itzel Yanira López-Peña, Francisco Rodríguez-Félix

    Curcuma longa L. rhizomes contain curcuminoids and other compounds of interest, but their incorporation into aqueous systems is limited by poor dispersibility and chemical instability. This study formulated gelatin–Curcuma longa L. extract nanoparticles by coaxial electrospraying. A dried hydroethanolic extract was obtained from commercial Curcuma longa L. powder by ultrasound-microwave-assisted extraction (UMAE), with a mean gravimetric yield of 12.46 ± 1.47%. Because the recovered material was not purified or quantified by a compound-specific method, it is described as Curcuma longa L. extract rather than curcumin. Gelatin solutions at 8 and 10% (w/v) were used as the outer feed, whereas extract solutions at 0.1, 0.5, and 1.0% (w/v) were used as the inner feed. The precursor solutions showed near-Newtonian behavior. The 8% gelatin–0.5% extract formulation exhibited predominantly spherical morphology, a hydrodynamic diameter of 266.27 ± 0.57 nm, and the lowest PDI (0.24 ± 0.01). FTIR-ATR results were consistent with non-covalent interactions, mainly hydrogen bonding. These findings support coaxial electrospraying as a suitable method for preparing gelatin–Curcuma longa L. extract nanoparticles.

  • Open Access

    Nanotechnology for Metformin Release Systems: Nanostructures, Biopolymer Carriers, and Techniques—A Review

    by Eneida Azaret Montaño-Grijalva, Francisco Rodríguez-Félix, José Agustín Tapia-Hernández, Enrique Márquez-Ríos, Carmen Lizette Del-Toro-Sánchez, Dora Evelia Rodríguez-Félix, Ricardo Nalda-Molina, Elizabeth Carvajal-Millan, Carlos Gregorio Barreras-Urbina, Itzel Yanira López-Peña, et al.

    Currently, there are various approaches to the treatment of diabetes. Regarding type 2 diabetes (T2D), treatment focuses on blood glucose control. When changes in lifestyle do not achieve this glycemic control, the option is to start therapy with antidiabetic drugs such as metformin. However, long-term metformin use causes disturbances that may affect treatment approaches. This review examines recent advances in nanotechnology that have developed new forms of drug administration that can improve the efficacy of the treatment, where nanomaterials, nanostructures, and nanoparticle design are involved, so that they provide controlled and gradual release. The use of biopolymers (as drug delivery systems) has ensured biocompatibility, biodegradability, and low toxicity. There are several methods for obtaining a drug delivery system, including electrospinning, electrospraying, nanoprecipitation, etc. These systems improve drug delivery and can be used orally, transdermally, or intravenously, among means of administration. This review describes the new forms of the administration of metformin in the treatment of T2D, based on the encapsulation of metformin in polymeric matrices such as proteins, polysaccharides, and lipids, among others.


  • Classification and Synthesis of Nano-Biopolymers

    by Itzel Yanira López-Peña, Carlos Gregorio Barreras-Urbina, Tomás Jesús Madera-Santana, David Servín de la Mora-López, Jocelyn Millán-Seaman, Eneida Azaret Montaño-Grijalva, José Agustín Tapia-Hernández, Francisco Rodríguez-Félix, Abraham Alejandro Leyva-Verduzco


  • Applications of Nano-biopolymers in Medicine and Environmental

    by Itzel Yanira López-Peña, Carlos Gregorio Barreras-Urbina, Tomás Jesús Madera-Santana, David Servín de la Mora-López, Jocelyn Millán-Seaman, Eneida Azaret Montaño-Grijalva, José Agustín Tapia-Hernández, Francisco Rodríguez-Félix, Abraham Alejandro Leyva-Verduzco

  • Open Access

    Nanotechnology for Metformin Release System: Nanostructures, Biopolymer Carriers, and Techniques: a Review

    by Eneida Azaret Montaño-Grijalva, Francisco Rodríguez-Félix, José Agustín Tapia-Hernández, Enrique Márquez-Ríos, Carmen Lizette Del-Toro-Sánchez, Dora Evelia Rodríguez-Félix, José Ricardo Nalda-Molina, Elizabeth Carvajal-Millan, Carlos Gregorio Barreras-Urbina, Itzel Yanira López-Peña, et al.

    Currently, there are various approaches in the treatment for diabetes. Speaking of type 2 diabetes (T2D), it focuses on blood glucose control. When changes in lifestyle do not achieve this glycemic control, the option is to start therapy with antidiabetic drugs such as metformin. However, long-term metformin uses causes disturbances that may affect treatment approaches. This review examines recent advances in nanotechnology that have developed new forms of drug administration that can improve the efficacy of the treatment, where nanomaterials, nanostructures and nanoparticle design are involved so that they provide controlled and gradual release. The use of biopolymers (as drug delivery systems have ensured biocompatibility, biodegradability, and low toxicity. There are several methods for obtaining a drug delivery system, including electrospinning, electrospraying, nanoprecipitation, etc. These systems improve drug delivery and can be used orally, transdermal, intravenously, among others. This review describes the new forms of administration of metformin in the treatment of T2D, based on the encapsulation of metformin in polymeric matrices such as proteins, polysaccharides, lipids, among others.